Romosozumab Treatment in Postmenopausal Women with Osteoporosis von Cosman, Felicia, Crittenden, Daria B, Adachi, Jonathan D, Binkley, Neil, Czerwinski, Edward, Ferrari, Serge, Hofbauer, Lorenz C, Lau, Edith, Lewiecki, E. Michael, Miyauchi, Akimitsu, Zerbini, Cristiano A.F, Milmont, Cassandra E, Chen, Li, Maddox, Judy, Meisner, Paul D, Libanati, Cesar, Grauer, Andreas

Volltext

Risk of imminent fracture following a previous fracture in a Swedish database study von Banefelt, J., Åkesson, K.E., Spångéus, A., Ljunggren, O., Karlsson, L., Ström, O., Ortsäter, G., Libanati, C., Toth, E.

Volltext

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis von Cummings, Steven R, Martin, Javier San, McClung, Michael R, Siris, Ethel S, Eastell, Richard, Reid, Ian R, Delmas, Pierre, Zoog, Holly B, Austin, Matt, Wang, Andrea, Kutilek, Stepan, Adami, Silvano, Zanchetta, Jose, Libanati, Cesar, Siddhanti, Suresh, Christiansen, Claus

Volltext

Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc anal... von Takada, Junichi, Dinavahi, Rajani, Miyauchi, Akimitsu, Hamaya, Etsuro, Hirama, Toshiyasu, Libanati, Cesar, Nakamura, Yoichi, Milmont, Cassandra E., Grauer, Andreas

Volltext

Romosozumab in Postmenopausal Women with Low Bone Mineral Density von McClung, Michael R, Grauer, Andreas, Boonen, Steven, Bolognese, Michael A, Brown, Jacques P, Diez-Perez, Adolfo, Langdahl, Bente L, Reginster, Jean-Yves, Zanchetta, Jose R, Wasserman, Scott M, Katz, Leonid, Maddox, Judy, Yang, Yu-Ching, Libanati, Cesar, Bone, Henry G

Volltext

Comparative Analysis of Health Outcomes Between Migrants and Native Spaniards von Libanati, John Paul

Volltext

One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study von Lewiecki, E Michael, Dinavahi, Rajani V, Lazaretti‐Castro, Marise, Ebeling, Peter R, Adachi, Jonathan D, Miyauchi, Akimitsu, Gielen, Evelien, Milmont, Cassandra E, Libanati, Cesar, Grauer, Andreas

Volltext

Romosozumab and antiresorptive treatment: the importance of treatment sequence von Cosman, Felicia, Kendler, David L., Langdahl, Bente L., Leder, Benjamin Z., Lewiecki, E. Michael, Miyauchi, Akimitsu, Rojeski, Maria, McDermott, Michele, Oates, Mary K., Milmont, Cassandra E., Libanati, Cesar, Ferrari, Serge

Volltext

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label,... von Langdahl, Bente L, Libanati, Cesar, Crittenden, Daria B, Bolognese, Michael A, Brown, Jacques P, Daizadeh, Nadia S, Dokoupilova, Eva, Engelke, Klaus, Finkelstein, Joel S, Genant, Harry K, Goemaere, Stefan, Hyldstrup, Lars, Jodar-Gimeno, Esteban, Keaveny, Tony M, Kendler, David, Lakatos, Peter, Maddox, Judy, Malouf, Jorge, Massari, Fabio E, Molina, Jose Fernando, Ulla, Maria Rosa, Grauer, Andreas

Volltext

Five years of denosumab exposure in women with postmenopausal osteoporosis: Results from the first two years of the FREEDOM extension von Papapoulos, Socrates, Chapurlat, Roland, Libanati, Cesar, Brandi, Maria Luisa, Brown, Jacques P, Czerwiński, Edward, Krieg, Marc-Antoine, Man, Zulema, Mellström, Dan, Radominski, Sebastião C, Reginster, Jean-Yves, Resch, Heinrich, Ivorra, José A Román, Roux, Christian, Vittinghoff, Eric, Austin, Matthew, Daizadeh, Nadia, Bradley, Michelle N, Grauer, Andreas, Cummings, Steven R, Bone, Henry G

Volltext

Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate von Seeman, Ego, Delmas, Pierre D, Hanley, David A, Sellmeyer, Deborah, Cheung, Angela M, Shane, Elizabeth, Kearns, Ann, Thomas, Thierry, Boyd, Steven K, Boutroy, Stephanie, Bogado, Cesar, Majumdar, Sharmila, Fan, Michelle, Libanati, Cesar, Zanchetta, Jose

Volltext

Bone mineral density gains with a second 12-month course of romosozumab therapy following placebo or denosumab von Kendler, D.L., Bone, H.G., Massari, F., Gielen, E., Palacios, S., Maddox, J., Yan, C., Yue, S., Dinavahi, R.V., Libanati, C., Grauer, A.

Volltext

Effects of denosumab on bone turnover markers in postmenopausal osteoporosis von Eastell, Richard, Christiansen, Claus, Grauer, Andreas, Kutilek, Stepan, Libanati, Cesar, McClung, Michael R, Reid, Ian R, Resch, Heinrich, Siris, Ethel, Uebelhart, Daniel, Wang, Andrea, Weryha, Georges, Cummings, Steve R

Volltext

Romosozumab followed by denosumab in Japanese women with high fracture risk in the FRAME trial von Miyauchi, Akimitsu, Hamaya, Etsuro, Yang, Wenjing, Nishi, Kiyoshi, Libanati, Cesar, Tolman, Cae, Shimauchi, Junichiro

Volltext

Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older von Söreskog, Emma, Ström, Oskar, Spångéus, Anna, Åkesson, Kristina E., Borgström, Fredrik, Banefelt, Jonas, Toth, Emese, Libanati, Cesar, Charokopou, Mata

Volltext

One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data von Khalid, Sara, Reyes, Carlen, Ernst, Martin, Delmestri, Antonella, Toth, Emese, Libanati, Cesar, Abrahamsen, Bo, Prieto-Alhambra, Daniel

Volltext

The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study von Papapoulos, S., Lippuner, K., Roux, C., Lin, C. J. F., Kendler, D. L., Lewiecki, E. M., Brandi, M. L., Czerwiński, E., Franek, E., Lakatos, P., Mautalen, C., Minisola, S., Reginster, J. Y., Jensen, S., Daizadeh, N. S., Wang, A., Gavin, M., Libanati, C., Wagman, R. B., Bone, H. G.

Volltext

Romosozumab in patients who experienced an on-study fracture: post hoc analyses of the FRAME and ARCH phase 3 trials von Lane, J., Langdahl, B., Stone, M., Kurth, A., Oates, M., Timoshanko, J., Wang, Z., Libanati, C., Cosman, F.

Volltext

Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment von Ferrari, S, Libanati, C, Lin, Celia Jow Fang, Brown, JP, Cosman, F, Czerwiński, E, Gregόrio, LH, Malouf‐Sierra, J, Reginster, J‐Y, Wang, A, Wagman, RB, Lewiecki, EM

Volltext

Secular trends in the initiation of therapy in secondary fracture prevention in Europe: a multi-national cohort study including data from Denmark, Catalonia, and the United Kingdom... von Skjødt, M. K., Khalid, S., Ernst, M., Rubin, K. H., Martinez-Laguna, D., Delmestri, A., Javaid, M. K., Cooper, C., Libanati, C., Toth, E., Abrahamsen, B., Prieto-Alhambra, D.

Volltext